title: Indications and contraindications for recombinant human erythropoietin treatment. Results in hemodialysis patients.
authors.affiliation: Nephrology Division, Medical Clinic I, Klinikum München-Grosshadern, Ludwig Maximilians University, Munich.
authors.forename: W
authors.initials: W
authors.lastname: Samtleben
authors.forename: C A
authors.initials: CA
authors.lastname: Baldamus
authors.forename: J
authors.initials: J
authors.lastname: Bommer
authors.forename: P
authors.initials: P
authors.lastname: Grützmacher
authors.forename: B
authors.initials: B
authors.lastname: Nonnast-Daniel
authors.forename: P
authors.initials: P
authors.lastname: Scigalla
authors.forename: H J
authors.initials: HJ
authors.lastname: Gurland
mesh_terms: D000740:Anemia / Q000150:complications / Q000188:drug therapy; D001166:Arteriovenous Shunt, Surgical / Q000009:adverse effects; D004921:Erythropoietin / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D006973:Hypertension / Q000139:chemically induced / Q000150:complications; D007676:Kidney Failure, Chronic / Q000150:complications / Q000628:therapy; D015337:Multicenter Studies as Topic; D009369:Neoplasms / Q000150:complications; D006435:Renal Dialysis; D012640:Seizures / Q000139:chemically induced; D013922:Thrombocytosis / Q000139:chemically induced; D013927:Thrombosis / Q000139:chemically induced
chemical_list: D004921:Erythropoietin